Osteopontin human, ;, recombinant, exprimé en HEK 293 cellules, > = 97 % (SDS - PAGE), >= 97%( HPLC) , testé sur la culture CELLULAIRE

Code: srp3131-50ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Osteopontin human has been used in in vitro invasion assay to study the effect of endostar on non small cell lung cancer cell invasion.

Bio...


en savoir plus

Votre prix
$388.30 50UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Osteopontin human has been used in in vitro invasion assay to study the effect of endostar on non small cell lung cancer cell invasion.

Biochem/physiol Actions

Osteopontin is a secreted glycoprotein that functions as a ligand to αvβ3 integrin and possibly other receptors. It binds tightly to hydroxyapatite and can act as a structural component of the extracellular mineralized matrix. In addition to its involvement in mineralized matrix formation, Osteopontin can also function as a cytokine that stimulates the release of IFNg (interferon γ) and IL-12 (interleukin 12), while inhibiting the production of IL-10. Osteopontin is involved in inflammation and also regulates immunity against infectious diseases. It also co-stimulates T cell proliferation. Osteopontin is also associated with multiple sclerosis. It participates in inflammation in Crohn′s Disease. Osteopontin plays a crucial role in bone remodelling and suppresses ectopic calcification.

General description

Osteopontin is initially secreted as a 298 amino acid protein, which is subject to multiple post-translational modifications including glycosylation, phosphorylation, and specific proteolytic cleavages into various smaller molecular weight fragments. Osteopontin is expressed in a wide range of cells and tissues including osteoblasts, various tumor cell lines, extraosseous cells in the inner ear, brain, kidney, deciduum, placenta and odontoblasts. Recombinant human Osteopontin is a 298 amino acid protein, which, due to glycosylation, migrates at an apparent molecular weight of 60.0-65.0kDa by SDS-PAGE analysis under reducing conditions.

Physical form

Lyophilized from 10 mM Sodium Phosphate, pH 7.0.

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.

Sequence

IPVKQADSGS SEEKQLYNKY PDAVATWLNP DPSQKQNLLA PQNAVSSEET NDFKQETLPS KSNESHDHMD DMDDEDDDDH VDSQDSIDSN DSDDVDDTDD SHQSDESHHS DESDELVTDF PTDLPATEVF TPVVPTVDTY DGRGDSVVYG LRSKSKKFRR PDIQYPDATD EDITSHMESE ELNGAYKAIP VAQDLNAPSD WDSRGKDSYE TSQLDDQSAE THSHKQSRLY KRKANDESNE HSDVIDSQEL SKVSREFHSH EFHSHEDMLV VDPKSKEEDK HLKFRISHEL DSASSEVN

assay≥97% (HPLC), ≥97% (SDS-PAGE)
biological sourcehuman
colorwhite to off-white
formlyophilized
Gene Informationhuman ... SPP1(6696)
impurities﹤0.1 EU/µg endotoxin, tested
mol wt60.0-65.0 kDa
packagingpkg of 50 µg
recombinantexpressed in HEK 293 cells
shipped inwet ice
storage temp.−20°C
technique(s)cell culture | mammalian: suitable
UniProt accession no.P10451
Ce produit répond aux critères suivants: